Open AccessCombined therapy versus anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy: a Meta-analysis
Author(s) -
Longhui Han,
Lifei Yuan,
Xu Liang,
Xin Jia,
Minglian Zhang
Publication year - 2017
Publication title -
international journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 29
eISSN - 2227-4898
pISSN - 2222-3959
DOI - 10.18240/ijo.2017.08.16
Subject(s) - medicine , combination therapy , adverse effect , photodynamic therapy , vascular endothelial growth factor , ophthalmology , incidence (geometry) , retinal , gastroenterology , vegf receptors , chemistry , physics , organic chemistry , optics
To evaluate the efficacy and safety of anti-vascular endothelial growth factor (VEGF) combined with photodynamic therapy (PDT) versus anti-VEGF monotherapy for polypoidal choroidal vasculopathy (PCV).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom